SGFG
PHAR icon

Silver Grove Financial Group’s Pharming Group PHAR Stock Holding History

Silver Grove Financial Group’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9K Buy
+1,071
New +$15.5K 0.01% 741

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Silver Grove Financial Group's PHAR Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Pharming Group (PHAR) in Q2 2026: 1,071 shares worth $14.9K. The stake represents 0.01% of the portfolio and ranks #741 among its holdings.

16 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • Silver Grove Financial Group held 1,071 shares of Pharming Group worth $14.9K as of Q2 2026.
  • Pharming Group was a new Silver Grove Financial Group position in Q2 2026.
  • Pharming Group made up 0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #741 holding.
  • 16 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.